Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Ltd. announced today that they have entered into a definitive agreement, under which Organon will acquire…
– 출처 : https://www.newswire.co.kr/newsRead.php?no=997121&sourceType=rss
